Find-Health-Articles.com - making medical research available to everyone
Research article summary (published May 2009):

A role for dopamine D2 receptors in reversal learning.

Full Abstract

Reversal learning has been shown to require intact serotonergic innervation of the forebrain neocortex. Whether dopamine acting through D2 receptors plays a complementary role in this anatomic area is still unclear. Here we show that mice lacking dopamine D2 receptors exhibited significantly impaired performance in the reversal learning phase of an attention-set-shifting task (ASST) and that wild type mice treated chronically with the D2-like receptor antagonist haloperidol exhibited the same cognitive deficit. The test-phase-specific deficits of D2 mutants and haloperidol-treated mice were also accompanied by deficits in the induction of expression of early growth response gene 2 (egr-2), a regulatory transcription factor previously shown to be selectively induced in the ventrolateral orbital frontal cortex and the pre- and infralimbic medial prefrontal cortex of ASST-tested mice. D2-receptor knockout mice and haloperidol-treated wild type, however, exhibited lower egr-2 expression in these anatomic regions after completion of an ASST-test phase that required reversal learning but not after completion of set-shifting phases without rule reversals. In contrast, mice treated chronically with clozapine, an atypical neuroleptic drug with lower D2-receptor affinity and broader pharmacological effects, had deficits in compound discrimination phases of the ASST, but also these deficits were accompanied by lower egr-2 expression in the same anatomic subregions. Thus, the findings indicate that egr-2 expression is a sensitive indicator of test-phase-specific performance in the ASST and that normal function of D2 receptors in subregions of the orbital frontal and the medial prefrontal cortex is required for cognitive flexibility in tests involving rule reversals.

 

Author information

Author/s: De Steno, D A (DA); Schmauss, C (C);

Affiliation: Department of Pharmacology, Columbia University, New York, NY 10032, USA.

Grants: MH062185 (Agency:NIMH NIH HHS) ; MH56123 (Agency:NIMH NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal: Neuroscience (Neuroscience), published in United States. (Language: eng)

Reference: 2009-Aug; vol 162 (issue 1) : pp 118-27

Dates: Created 2009/06/09; Completed 2009/08/25;

PMID: 19401217, status: MEDLINE (last retrieval date: 8/25/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Dopamine Antagonists (0) ; Early Growth Response Protein 2 (0) ; Egr2 protein, mouse (0) ; Neurotransmitter Agents (0) ; RNA, Messenger (0) ; Receptors, Dopamine D2 (0) ; Haloperidol (52-86-8) ; Clozapine (5786-21-0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

11/27/1996
11/29/2007
Higher Relevance Score (100)
Lower Relevance Score (66)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index